Prices not likely to change upon release.In a move to compete with AbbVie’s rheumatoid arthritis drug Humira, drugmakers Boehringer Ingelheim, Sandoz, and Organon are expected to launch copycat versions of the drug this month. Despite price decreases that usually come with generic versions of a previously patented medication, manufacturers are expected to keep prices high […]
